Pregnancy after the age of 35, is associated with many complications. Not only for the baby (including many congenital genetic defects), but also for the mother.
Ad:
The benefits of hormonal contraception in premenopause are a reduced risk of:
- ovarian cancer - by 40%,
- endometrial cancer - by 40%,
- benign breast diseases - by 40%,
- functional ovarian cysts - by 78%,
- uterine myomas,
- pelvic inflammatory conditions - by 50%,
- heavy menstrual bleeding - by 50%,
- painful menstrual periods - by 50%.
According to the observation of 252 cycles of low-dose oral hormonal contraception used in women aged 36-44 years, there was a reduction in heavy menstrual bleeding in approximately 88% and a reduction in painful menstruation in 90% of patients.
photo: pantherstock
Breast cancer and venous thromboembolism are of greatest concern in relation to the risk of DHT in the premenopausal period. Contraception during this period should be avoided by women:
- cigarette smokers,
- obese,
- with high blood pressure,
- at increased risk of thrombosis,
- with ischaemic heart disease.
